Goldman Lenka, Ezzat Sameera, Mokhtar Nadia, Abdel-Hamid Amany, Fowler Nathan, Gouda Iman, Eissa Soheir Abdel Latif, Abdel-Hamid Mohamed, Loffredo Christopher A
Lombardi Cancer Center, Georgetown University, 3800 Reservoir Rd, PO Box 571465, Washington, DC 20057-1465, USA.
Cancer Causes Control. 2009 Aug;20(6):981-7. doi: 10.1007/s10552-009-9316-0. Epub 2009 Mar 5.
Non-Hodgkin's lymphomas (NHL) are etiologically heterogeneous malignancies. In Egypt, we previously reported an association of increased NHL risk with chronic hepatitis C virus (HCV) infection. Our present aim is to assess the association between HCV infection and histological subtypes of NHL.
We conducted a case-control study at the National Cancer Institute of Cairo University. Cases with NHL (n = 486) were matched to controls (n = 786) who were orthopedic patients from the same referral regions. Participants provided a blood sample for HCV markers (anti-HCV, HCV RNA) and answered a questionnaire on possible risk factors. Case-control differences were assessed by odds ratios and 95% confidence intervals from logistic regression analysis.
Cases with diffuse large B cell lymphoma (n = 146), chronic lymphocytic leukemia (n = 58), marginal zone lymphoma (n = 24), follicular lymphoma (n = 23), and mantle cell lymphoma (n = 16) were recruited. HCV RNA prevalence was 27% in controls and 26%-48% in the NHL subgroups: it was associated (p < 0.001) with diffuse large B cell, marginal zone, and follicular lymphomas with odds ratios of 3.2, 4.4, and 3.3, respectively.
HCV is a risk factor for diffuse large B cell, marginal zone, and follicular lymphomas in Egypt.
非霍奇金淋巴瘤(NHL)是病因学上异质性的恶性肿瘤。在埃及,我们之前报道过NHL风险增加与慢性丙型肝炎病毒(HCV)感染有关。我们目前的目的是评估HCV感染与NHL组织学亚型之间的关联。
我们在开罗大学国家癌症研究所进行了一项病例对照研究。NHL病例(n = 486)与来自相同转诊地区的骨科患者作为对照(n = 786)进行匹配。参与者提供血液样本检测HCV标志物(抗-HCV、HCV RNA),并回答关于可能风险因素的问卷。通过逻辑回归分析的比值比和95%置信区间评估病例对照差异。
招募了弥漫性大B细胞淋巴瘤病例(n = 146)、慢性淋巴细胞白血病病例(n = 58)、边缘区淋巴瘤病例(n = 24)、滤泡性淋巴瘤病例(n = 23)和套细胞淋巴瘤病例(n = 16)。对照组中HCV RNA流行率为27%,NHL各亚组中为26% - 48%:它与弥漫性大B细胞淋巴瘤、边缘区淋巴瘤和滤泡性淋巴瘤相关(p < 0.001),比值比分别为3.2、4.4和3.3。
在埃及,HCV是弥漫性大B细胞淋巴瘤、边缘区淋巴瘤和滤泡性淋巴瘤的一个风险因素。